A detailed history of Cullen/Frost Bankers, Inc. transactions in Quest Diagnostics Inc stock. As of the latest transaction made, Cullen/Frost Bankers, Inc. holds 1,000 shares of DGX stock, worth $137,090. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,000
Previous 1,000 -0.0%
Holding current value
$137,090
Previous $136,000 0.74%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 04, 2023

BUY
$130.56 - $146.84 $129,907 - $146,105
995 Added 19900.0%
1,000 $140,000
Q3 2022

Nov 07, 2022

BUY
$121.77 - $141.1 $608 - $705
5 New
5 $1,000
Q2 2022

Aug 05, 2022

SELL
$127.07 - $145.39 $2,160 - $2,471
-17 Closed
0 $0
Q1 2022

May 09, 2022

BUY
$129.09 - $164.35 $2,194 - $2,793
17 New
17 $2,000
Q4 2020

Feb 08, 2021

SELL
$112.7 - $128.05 $1,239 - $1,408
-11 Closed
0 $0
Q3 2020

Nov 05, 2020

BUY
$107.05 - $130.01 $1,177 - $1,430
11 New
11 $1,000
Q2 2020

Aug 05, 2020

SELL
$73.34 - $122.61 $8,507 - $14,222
-116 Closed
0 $0
Q1 2020

May 01, 2020

SELL
$75.14 - $115.68 $1,577 - $2,429
-21 Reduced 15.33%
116 $9,000
Q4 2019

Feb 06, 2020

SELL
$100.29 - $107.99 $42,422 - $45,679
-423 Reduced 75.54%
137 $15,000
Q3 2019

Nov 01, 2019

SELL
$97.85 - $107.42 $9,393 - $10,312
-96 Reduced 14.63%
560 $60,000
Q2 2019

Aug 01, 2019

SELL
$85.18 - $101.94 $108,348 - $129,667
-1,272 Reduced 65.98%
656 $67,000
Q1 2019

Apr 30, 2019

BUY
$80.68 - $89.92 $155,551 - $173,365
1,928 New
1,928 $173,000
Q4 2018

Feb 06, 2019

SELL
$79.75 - $108.38 $172,499 - $234,425
-2,163 Closed
0 $0
Q3 2018

Oct 29, 2018

BUY
$105.42 - $114.99 $18,448 - $20,123
175 Added 8.8%
2,163 $233,000
Q2 2018

Jul 27, 2018

BUY
$97.35 - $113.14 $193,531 - $224,922
1,988 New
1,988 $218,000

Others Institutions Holding DGX

About QUEST DIAGNOSTICS INC


  • Ticker DGX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 113,887,000
  • Market Cap $15.6B
  • Description
  • Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers dia...
More about DGX
Track This Portfolio

Track Cullen/Frost Bankers, Inc. Portfolio

Follow Cullen/Frost Bankers, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cullen/Frost Bankers, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cullen/Frost Bankers, Inc. with notifications on news.